Cialis Sales Jump 39% In Second Quarter, Exceeding $1 Bil. Since Launch
This article was originally published in The Pink Sheet Daily
Executive Summary
Cumulative worldwide sales of Cialis (tadalafil) since its 2003 launch have exceeded $1 bil., Lilly/Icos reported Aug. 4
You may also be interested in...
Erectile Dysfunction Class Labeling Does Not Assert Causal Link To Vision Loss
Labeling revisions for Viagra, Levitra and Cialis will add information about NAION adverse events, but states that “it is not possible to determine whether these events are related directly to the use of PDE5 inhibitors or to other factors.”
Pfizer's Revatio Clears FDA For Pulmonary Arterial Hypertension
Revatio has the same active ingredient as Viagra, which the company markets for erectile dysfunction, but differs in dosing, pill color and pill shape. Pfizer will launch sildenafil for PAH in mid-July.
With Winrevair Approved, Merck Has A Chance To Execute On CV Strategy
The activin signaling inhibitor sotatercept was approved by the US FDA for pulmonary arterial hypertension.